Arquivamento definitivo - Art. 33 da LPI
#11.1.1
03/24/2020
RPI 2568
Application data
Number
112018012884Type
Filing
Publication
PCT
US2016068103 The application was abandoned: examination was not requested within the 36 months following the 12/21/2016 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 03/24/2020. We update with every new RPI gazette, published weekly.
Applicants
ABBVIE STEMCENTRX LLC
US
Inventors
C. F. (pessoa física)
US
D. C. (pessoa física)
US
D. L. (pessoa física)
US
L. S. (pessoa física)
US
S. W. (pessoa física)
US
S. D. (pessoa física)
US
S. R. (pessoa física)
US
Z. H. (pessoa física)
US
IPC Classification
Priority claims
US
62/270,846 · 12/22/2015
US
62/433,759 · 12/13/2016
Abstract
São proporcionados novos anticorpos anti-MMP16 e conjugados de fárma-co-anticorpo e métodos de uso de tais anticorpos anti-MMP16 e conjugados de fár-maco-anticorpo para tratar o câncer.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.1.1
03/24/2020
RPI 2568
#11.1
01/07/2020
RPI 2557
#1.3
12/04/2018
RPI 2500
#1.1
07/03/2018
RPI 2478
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.